Clinical Trial Update: Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma [Phase 3]

View source ↗

Summary

A Phase 3 trial is recruiting to test dinutuximab plus chemotherapy, surgery, and stem cell transplantation for newly diagnosed high-risk neuroblastoma in child…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ganglioneuroblastoma
• Neuroblastoma

Drugs mentioned

• dinutuximab (dinutuximab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ganglioneuroblastoma, Nodular, Neuroblastoma | Phase 3 | Status: RECRUITING